A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
Dementia, Alzheimer Disease, Dementia, Vascular
About this trial
This is an interventional treatment trial for Dementia focused on measuring Dementia, Alzheimer's Disease, vascular dementia, mixed dementia, risperidone, nursing home
Eligibility Criteria
Inclusion Criteria: Patients with dementia of the Alzheimer's type, mixed dementia, or vascular dementia, (as classified by the Diagnostic and Statistical Manual of Mental Diseases, 4th edition [DSM-IV]) and have behavioral disturbances a score >=4 on the FAST a score <=23 on the MMSE a BEHAVE-AD total score >=8, and a BEHAVE-AD global rating >=1 must be institutionalized. Exclusion Criteria: Patients with other medical or neurological conditions in which cognition (thinking, perception, learning, verbal communication, memory, judgment) is diminished (for example, drug overdosage, severe liver, heart, lung, and kidney malfunctions, Parkinson's disease) other psychiatric disorders, including major depression, schizophrenia, substance abuse or dependence abnormal electrocardiogram (ECG) findings abnormal clinical laboratory test findings.